Bain Capital Specialty Finance, Inc. (BCSF) Market Cap & Valuation Ratios
Bain Capital Specialty Finance, Inc. (BCSF) has a market cap of $653.2M, a trailing P/E of 10.2 and a price-to-sales ratio of 2.5, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
BCSFBain Capital Specialty Finance, Inc.Follow BCSF — free
—
Price chart with a free account
- Market cap
- 653.2M
- P/E TTM
- 10.2
- Dividend yield
- 18.8%
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
Peers
asset management · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | P/B | ROE | Div. yield | Rev. growth |
|---|---|---|---|---|---|---|
| BCSF | 0.7 | 10.2 | 0.60 | 6% | 18.8% | -7% |
| ABX | 0.8 | 30.7 | 1.87 | 7% | 2.4% | +65% |
| VRTS | 0.8 | 6.8 | 0.84 | 13% | 8.0% | -7% |
| PSEC | 0.8 | 37.0 | 0.27 | 5% | — | -11% |
| BUR | 0.7 | — | 0.90 | -102% | 3.7% | — |
| FDUS | 0.7 | 8.6 | 0.95 | 11% | 11.9% | +12% |
| CGBD | 0.7 | 20.4 | 0.65 | 3% | 16.4% | +11% |
| PFLT | 0.6 | — | 0.62 | 5% | 19.3% | +9% |
| NMFC | 0.6 | — | 0.61 | -4% | 18.1% | -19% |
| SLRC | 0.6 | 8.3 | 0.62 | 7% | — | -6% |
| GAIN | 0.6 | 3.4 | 0.90 | 29% | 6.5% | +9% |
| Median of these 10 | 8.6 | 0.74 | 6% | 10.0% | +9% |
P/E 10.2 vs. a peer median of 8.6; P/B 0.60 vs. 0.74. BCSF's own P/E sits at the 90th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesBUR and PFLT and NMFC have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Bain Capital Specialty Finance, Inc. — questions
- What is Bain Capital Specialty Finance, Inc.'s market cap?
- $653.2M.
- What is Bain Capital Specialty Finance, Inc.'s P/E ratio?
- 10.2 on trailing twelve-month earnings to 2026-06-30.
- What is Bain Capital Specialty Finance, Inc.'s price-to-sales ratio?
- 2.5.
Every figure on this page comes from Bain Capital Specialty Finance, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.